Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-12-067741
Filing Date
2012-02-17
Accepted
2012-02-17 17:17:05
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d303715d424b5.htm 424B5 444816
2 GRAPHIC g303715g29a33.jpg GRAPHIC 12826
3 GRAPHIC g303715g37e58.jpg GRAPHIC 12863
4 GRAPHIC g303715g68n37.jpg GRAPHIC 8406
5 GRAPHIC g303715g77o20.jpg GRAPHIC 4086
6 GRAPHIC g303715g82s35.jpg GRAPHIC 31780
  Complete submission text file 0001193125-12-067741.txt   543212
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-167025 | Film No.: 12623809
SIC: 2834 Pharmaceutical Preparations